SAUSAN ABOUHARB to Immunoconjugates
This is a "connection" page, showing publications SAUSAN ABOUHARB has written about Immunoconjugates.
Connection Strength
0.148
-
A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer. Invest New Drugs. 2021 04; 39(2):509-515.
Score: 0.148
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.